The 6th China Bio-Pharm Partnering Forum kicked off in SIP on Aug 4. On the two-day schedule were keynote reports, specialized forums, roundtables, partnering activities, an exhibition and an award ceremony designed to promote exchanges and cooperation in the biomedical industry.
More than 100 industrial experts and professionals got together at the event to share their expertise, discuss issues related to development and marketing of new drugs, and seek cooperation opportunities.
At the exhibition, the booth of TOT Biopharm and BrightGene attracted many visitors. TOT Biopharm specializes in development and commercialization of anti-tumor drugs and therapies, while BrightGene is engaged in making novel and generic drugs. Both located in SIP, the two companies are joining hands in building a one-stop CDMO (contract development and manufacturing organization) service platform for development of antibody-drug conjugates (ADCs).
August 4, 2022
